Health
Chronicle Pharmabiz
FOPE urges Petroleum Min to prioritise LPG supply to pharma sector
THE Federation of Pharma Entrepreneurs (FOPE) is now concerned about the shortage of LPG (Liquefied Petroleum Gas) following the looming uncertainty with the ongoing war in West Asia.
1 min |
March 19, 2026
Chronicle Pharmabiz
BDCDA informs FDA about challenges to implement geo-tagging
THE Bangalore District Chemists and Druggists Association (BDCDA) has apprised the Karnataka FDA about the practical challenges in implementing the FDA's geo-tagging application.
1 min |
March 19, 2026
Chronicle Pharmabiz
₹1,000 cr MedTech Fund signals shift toward domestic mfg
THE Indian medical technology sector is poised for a major transformation with the launch of MedArtha Capital, the nation’s first dedicated Rs.1,000 crore growth fund focused exclusively on medtech.
1 min |
March 19, 2026
Chronicle Pharmabiz
Pharma exports to GCC countries affected by US-Israel-Iran conflict: Experts
PHARMA exports to the Gulf Cooperation Council (GCC) countries like UAE, Saudi Arabia and West Asia-North Africa (WANA) region have been badly affected due to the USIsrael-Iran conflict.
2 min |
March 19, 2026
Chronicle Pharmabiz
SEPC, AHPI hold program for wellness centres & MVTF
THE Services Export Promotion Council (SEPC) India and the Association of Healthcare Providers (AHPI) India successfully held its first meeting recently on creating an accreditation programme for Wellness Centers and Medical Value Travel Facilitators (MVTF).
1 min |
March 19, 2026
Chronicle Pharmabiz
DGFT launches risk sharing support to boost exports
IN a strategic move to expand India's global export footprint, the DGFT has introduced a new intervention under the Export Promotion Mission (EPM) aimed at strengthening export financing and improving trade access to under-served markets.
1 min |
March 19, 2026
Chronicle Pharmabiz
'Need to transition from awareness reporting to performance-oriented PV'
THERE is a need to transition from awareness-driven reporting to a performance-oriented pharmacovigilance (PV) framework with measurable outcomes, said Dr V Kalaiselvan, secretary-cum-scientific director, the Indian Pharmacopoeia Commission (IPC) at the 1st Annual Meeting of Regional Centres participating in the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI).
1 min |
March 19, 2026
Chronicle Pharmabiz
India's drug quality surveillance hits new highs
THE Central Drugs Standard Control Organisation (CDSCO) has released a comprehensive report detailing the quality surveillance of pharmaceuticals across India over the last five fiscal years.
2 min |
March 19, 2026
Chronicle Pharmabiz
Pharma Quality Excellence Awards 2026 in Mumbai
In an era of heightened regulatory scrutiny, global supply chain complexity, and accelerated innovation, compliance alone is no longer sufficient.
1 min |
March 19, 2026
Chronicle Pharmabiz
Healthcare workforce eyes AI dominance via digital upskilling
INDIA'S healthcare workforce, armed with digital upskilling, is poised for AI dominance, but there are certain creases in the system that need to be ironed out for more efficient integration.
1 min |
March 19, 2026
Chronicle Pharmabiz
AstraZeneca's Imfinzi in combo receives EU nod
ASTRAZENECA'S Imfinzi (durvalumab) in combination with standard-ofà care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the European Union (EU) for the treatment of adult patients with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric and gastroesophageal junction (GEJ) cancers.
1 min |
March 19, 2026
Chronicle Pharmabiz
DTAB recommends to amend Sch K to allow unflavoured nicotine sold under exemption
THE Drugs Technical Advisory Board (DTAB) has recommended amendment of Schedule K of the Drugs Rules, 1945 to restrict the over-the-counter sale of nicotine gums to unflavoured nicotine gums 2 mg, and to exclude nicotine lozenges 2 mg from the Schedule so that it should be sold under the provisions of sale license.
3 min |
March 19, 2026
Chronicle Pharmabiz
Precision medicine, reimbursement: Next frontier for payers & providers
PRECISION medicine has transformed healthcare from organ-based treatment algorithms to biologically stratified care.
4 min |
March 19, 2026
Chronicle Pharmabiz
Centre to amend Rules to mandate PAC submission to licensing authority
THE Union Health Ministry has issued a draft amendment to various rules under the D&C Rules, 1945, to include requirement of the manufacturing and loan licenses for drugs, biopharmaceuticals, and those under the Indian Systems of Medicine, among others, mandating submission of information related to post approval changes (PACs) with the licensing authority.
1 min |
March 19, 2026
Chronicle Pharmabiz
RDCA celebrates 30 years of leadership in Delhi's pharma trade
THE Retail Distribution Chemists Alliance (RDCA), the apex body for pharmaceutical traders in the National Capital Territory of Delhi, is commemorating a landmark 30-year journey of service to the industry.
1 min |
March 19, 2026
Chronicle Pharmabiz
IPC to host 37th Skill Devpt Programme on PV
THE Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India (NCC-PvPI), is set to host the 37th Skill Development Programme (SDP) on Pharmacovigilance (PV) scheduled from 15 to 19 June, 2026 through offline or classroom mode.
1 min |
March 19, 2026
Chronicle Pharmabiz
IIT Roorkee opens Ashok Soota molecular medicine facility at BSBE
INDIAN Institute of Technology Roorkee (IIT Roorkee) inaugurated the Ashok Soota Molecular Medicine Facility at the Department of Biosciences and Bioengineering (BSBE), marking a significant step in strengthening advanced biomedical research infrastructure aligned with national healthcare priorities and global scientific advancements.
1 min |
March 19, 2026
Chronicle Pharmabiz
INTERPHEX Week Tokyo 2026 to be held from May 20 to 22 at Makuhari Messe
INTERPHEX Week Tokyo 2026, one of Japan’s largest and most influential trade shows for the pharmaceutical and biotechnology sectors, is set to return from May 20 to 22 at Makuhari Messe with an expanded showcase expected to surpass its 2025 performance and deliver a more dynamic experience for global industry professionals.
1 min |
March 19, 2026
Chronicle Pharmabiz
PCRM notes Karnataka's 18% of urban kids are obese, raising health concerns
PHYSICIANS Committee for Responsible Medicine (PCRM) notes Karnataka's 18% of urban children are obese and raising health concerns.
2 min |
March 19, 2026
Chronicle Pharmabiz
'Biopharma Shakti can power India's rise as a global hub'
UNION government's Biopharma Shakti initiative, combined with faster and more adaptive regulatory processes, has the potential to transform India into a global hub for biotechnology and pharmaceutical innovation.
2 min |
March 19, 2026
Chronicle Pharmabiz
DTAB agrees with proposal to add GDP as part of D&C Rules
THE Drugs Technical Advisory Board (DTAB), which recommends on policy decisions related to technical matters on the Drugs and Cosmetics Act and relevant rules, has given its green signal to amend the Drugs and Cosmetics Rules, 1945 to incorporate guidelines on Good Distribution Practices (GDP) for pharmaceutical products.
2 min |
March 19, 2026
Chronicle Pharmabiz
KSRPO alerts FDA about spurious drugs sold by fake doctors
THE Karnataka State Registered Pharmacists' Organisation (KSRPO) has alerted the State FDA and the government about the sale of spurious drugs by fake doctors at their illegal clinics.
1 min |
March 19, 2026
Chronicle Pharmabiz
CPHI & PMEC China to take place from June 16 to 18
CPHI & PMEC China, Asia’s premier pharmaceutical event for sourcing, networking, learning and innovation with over 20 years’ experience of bringing together Chinese and global pharma professionals, will be held from June 16-18 ,2026 at SNIEC (Shanghai New International Expo Centre), Shanghai, China.
1 min |
March 19, 2026
Chronicle Pharmabiz
CDSCO mandates application process of r-DNA products only via ONDLS portal
IN order to streamline the regulatory submission procedures related to grant of license and loan license to manufacturers of recombinant DNA (r-DNA) products, the CDSCO has announced that the applications for such approvals will now be available only through the online system.
1 min |
March 19, 2026
Chronicle Pharmabiz
Pharmexcil recommends diversification of shipping routes
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) has recommended diversification of shipping routes and exploration of alternate logistics options in the wake of tensions in the Gulf region.
1 min |
March 19, 2026
Chronicle Pharmabiz
'Genomics to touch every branch of medicine ranging from oncology to infectious diseases'
WE are now entering an era where genomics will touch every branch of medicine, ranging from oncology and rare diseases to infectious disease surveillance and preventive health.
2 min |
March 19, 2026
Chronicle Pharmabiz
Govt to amend Rules to issue licence for marketers
THE Drugs Technical Advisory Board (DTAB) has recommended to the national drug regulator to amend Drugs and Cosmetics Rules, 1945, to frame rules to issue licenses to pharmaceutical marketers for monitoring and better regulatory control.
1 min |
March 19, 2026
Chronicle Pharmabiz
Karnataka govt expands scope of acute malnutrition related procedures
KARNATAKA government will implement AB PM-JAY CM's Ark Scheme with the objective of providing universal health coverage to eligible beneficiaries in the state.
1 min |
March 19, 2026
Chronicle Pharmabiz
TNHDA issues report on Coldrif tragedy, calls for major drug regulatory reforms
THE Tamil Nadu Health Development Association (TNHDA), a prominent organization of healthcare professionals led by Dr. Rex Sargunam, former director of the Institute of Child Health (ICH) in Chennai, one of the premier paediatric institutions in India, has released a critical assessment of the state's Drug Control Department following the Coldrif cough syrup tragedy.
1 min |
March 19, 2026
Chronicle Pharmabiz
CDSCO delegates powers to Zonal Offices to issue NOC for vet drugs
THE Central Drugs Standard Control Organisation (CDSCO) has delegated powers to issue test licenses for import of veterinary drugs other than biologicals, and to issue No Objection Certificates (NOCs) related to this, to the zonal offices, in order to enhance ease of doing business.
2 min |